attention deficit hyperactivity disorder

Pfizer Has Announced The Availability of ADHD Therapy
Jan 16, 2013
Pfizer has announced the availability of attention deficit hyperactivity disorder (ADHD) therapy, Quillivant XR (methylphenidate hydrochloride) CII for extended-release oral suspension, in the US. The extended-release liquid ...

Tags: Pfizer, ADHD therapy, Quillivant XR CII
Pfizer Is Considering Buying Nextwave Pharmaceuticals
Dec 3, 2012
Pfizer is considering buying NextWave Pharmaceuticals, a company that develops a liquid attention deficit hyperactivity disorder drug. In the second quarter of 2012, Pfizer signed an option and merger agreement with NextWave and made a ...

Tags: Pfizer, NextWave Pharmaceuticals, deficit hyperactivity disorder drug
Nextwave Pharmaceuticals Are Taken Over by Pfizer
Nov 29, 2012
Pfizer has announced the completion of its purchase of a specialty pharmaceutical company NextWave Pharmaceuticals. Through the acquisition,Pfizer has gained exclusive North American commercialization rights to the FDA approved Quillivant ...

Tags: Pfizer, specialty pharmaceutical company, NextWave Pharmaceuticals